Invest in France Agency spain Office

The cluster’s objective is to create a synergistic environment favorable to the development of innovative products and processes for nutrition and health through the production of new medicine and foods and the anticipation of health and safety quality requirements.

This objective involves many factors:
Wealth creation    Creation of jobs    Innovation    Industrial development
Regional development    Attractiveness    Creation of businesses    Emergence of new participants

Advantages

The cluster has a privileged place in its sector of activity in the country
Agri-Food, Nutrition and Health sectors in Aquitaine

Companies and Jobs   
40,000 industrial jobs
Over 600 companies
   
Research   
1,500 researchers, 300 PhD students
130 university laboratories
 
Training
4 universities
4 engineering schools
Training from Bac to Bac+11

Members

Over 110 members

Companies: 77 
• French companies: Air Liquide, Sanofi-Aventis, Labeyrie, Pierre Fabre, Bonduelle, Total, Syngenta Seeds, Bertin, Bongrain etc.

• International companies: Bristol-Myers Squibb (United States), B. Braun Melsungen (Germany), Monsanto (United States), Lindt&Sprungli (Switzerland), Lu, subsidiary of Kraft Foods (United States), Altadis (France-Spain) etc.

• 50 small-and-medium-sized enterprises (SME): Tournay biotechnologies, Biolandes, Berkem, Saf Isis, Galenix, Inflamed, Mitoprod, Vitamont, Vitagermine etc.

Research and Educational Institutions

20 centers, including the Institut National de la Recherche Agronomique (INRA), Institut National Français de Recherche pour l’Exploitation de la Mer (IFREMER), Université de Bordeaux Sciences et Technologies, Université de Bordeaux Victor Segalen, Institut européen de Chimie et Biologie, Institut de Santé Publique, d’Epidémiologie et de Développement, Institut des Sciences de la Vigne et du Vin, Université de Pau et du Pays de l’Adour etc.

Almost 20 other organizations are also partners of the cluster, including Bordeaux Montesquieu, Incubateur Régional d’Aquitaine, Innovalis Aquitaine, Agropole d’Agen, Regional Council of Aquitaine etc.

Current R&D Partnerships (refer to appendix)

36 projects have been certified and financed as at the end of 2007, for a total amount of € 56 million and public subsidies at the level of € 18 million 

Public support examples:
• 8 million euros granted by the National Research Agency (Agence Nationale de la Recherche or ANR) between 2005 and 2007
• € 6.5 million provided by the Regional Council of Aquitaine
• Over 2 million euros allocated by the Single Interministerial Fund (Fonds Unique Interministériel or FUI) in the same period
• € 1.5 million granted by OSEO

International Partnerships

Current
- French-Canadian Scientific Symposium in Quebec in May 2008
- Participation in Bio Boston, United States
 -Participation in Vitafoods International exhibition, Switzerland
- And in Eurobio convention, Paris

Future
- Business mission to the Basque region in November 2008
- “Health” export missions with the CCI: Japan/Korea and Singapore/Australia
- Participation in the Health Ingredients Europe show in Paris

Appendix: Selected certified R&D Projects

A major structuring project: Industrial Biodevelopment Park

- A 10,000m² cluster of laboratories, pilot production workshops (GMP) and administrative offices
- 7 companies involved

Objectives:
•    Cost-effective shared resources and equipment
•    Cluster together pharmaceutical and biotech companies at all stages of their growth
•    Enhance scientific public/private partnerships
•    Promote these companies and their local partners

Budget: € 25 million; Public Funding: € 313,619

• More information on Prod'Innov